Showing results (831-840 of 996) with videos related to
Sort By:
Pageof 100
The Lancet. Oncology|March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation studyGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.Family Process|October 25, 2016
Longitudinal Effects of Latino Parent Cultural Stress, Depressive Symptoms, and Family Functioning on Youth Emotional Well-Being and Health Risk BehaviorsElma I Lorenzo-Blanco, Alan Meca, Jennifer B Unger, et al.Child Development|August 24, 2017
Longitudinal Trajectories of Family Functioning Among Recent Immigrant Adolescents and Parents: Links With Adolescent and Parent Cultural Stress, Emotional Well-Being, and Behavioral HealthElma I Lorenzo-Blanco, Alan Meca, Brandy Piña-Watson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrenceMichael D Allen, Gareth J Thomas, Sarah Clark, et al.Science Advances|July 4, 2025
SARS-CoV-2 induces Alzheimer's disease-related amyloid-β pathology in ex vivo human retinal explants and retinal organoidsSean J Miller, Rahul M Dhodapkar, Hande Eda Sutova, et al.International Journal of Molecular Sciences|September 23, 2022
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and PancreasJessica Iorio, Lorenzo Antonuzzo, Emanuela Scarpi, et al.NPJ Breast Cancer|November 16, 2017
A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancerJoseph A Sparano, Robert Gray, Maja H Oktay, et al.The Oncologist|February 22, 2017
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast CancerLinda T Vahdat, Rachel Layman, Denise A Yardley, et al.Journal of Geriatric Oncology|June 5, 2025
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty indexDaniela Krepper, Francesco Sparano, Johannes M Giesinger, et al.Pageof 100